Investigation Overview
The announcement by Immucor that it agreed to be acquired by TPG Capital prompted an investigation on behalf of investors of Immucor, Inc. (NASDAQ: BLUD) concerning whether the offer to take over Immucor, Inc. and the sale process are unfair to investors of Immucor (BLUD) and whether certain of its officers and directors or others breached their fiduciary duties owed investors in Immu...
You must register (for free) or login to view the entire investigation.